EUGENE, OR / ACCESSWIRE / September 20, 2024 / Papé Kenworth is thrilled to announce its newest partnership agreement with ...
ORLANDO, FL / ACCESSWIRE / September 20, 2024 / RedChip Companies will air interviews with Nova Minerals Limited (Nasdaq:NVA) and Soligenix Inc. (Nasdaq:SNGX) on the RedChip Small Stocks, Big Money sh ...
LIPID inCode tests patients to identify familial hypercholesterolemia and prevent cardiovascular diseaseOXFORD, ENGLAND / ACCESSWIRE / September 20, 2024 / GENinCode Plc (AIM:GENI), the genetics compa ...
Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral cannabinoid receptor 1]. The trial investigated ...
ONTARIO, CA / ACCESSWIRE / September 20, 2024 / Focus Universal Inc. (NASDAQ:FCUV) ("Focus" or the "Company"), a provider of patented hardware and software design technologies for Internet of Things ( ...
Research from Funnel outlines the mounting risks facing marketing agencies and the opportunities for adaptation STOCKHOLM, Sept. 20, 2024 /PRNewswire/ -- Funnel ( the marketing ...
FOR USE IN LOGISTIC TRUCKS AND PASSENGER VEHICLESSCOTTSDALE, AZ / ACCESSWIRE / September 20, 2024 / Sept 20 , 2024, Scottsdale, AZ, RONN Inc (OTC PINK:RONN) announced that the Company has officially f ...
BARCELONA, Spain, Sept. 20, 2024 /PRNewswire/ -- On September 19, HUAWEI officially launched the GoPaint Worldwide Creating ...
Die Puma SE verzeichnete am Freitag einen signifikanten Kursrückgang an der Börse. Das Wertpapier des Sportartikelherstellers verbuchte einen beträchtlichen Verlust von 5,99 Prozent, was es zu einem d ...
WESTON (dpa-AFX) - Samsung Bioepis, and Biogen (BIIB) announced the European Medicines Agency's CHMP has adopted a positive opinion for OPUVIZ 40 mg/mL solution for injection in a vial, a biosimilar ...
Im Minus liegt gegenwärtig der Anteilsschein von PNE . Zuletzt zahlten Investoren für das Papier 11,30 Euro. Ein Abschlag von 3,58 Prozent steht gegenwärtig für der Anteilsschein von PNE zu Buche. Die ...
Nach einer Kaufempfehlung der Deutschen Bank geht die Erholungsrally der Aktie von Atoss Software vor dem Wochenende weiter. Vor zwei Wochen büßte der Titel nach einer Platzierung durch den Großaktion ...